Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hede Shen

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Discover Oncology|April 24, 2026
Uterine carcinosarcoma with concurrent right nephrolithiasis case reportHede Shen, Li He, Xia Ye, et al.
Scientific Reports|April 27, 2026
RETN and BMP2 as potential biomarkers for prognosis and immune landscape in lung squamous cell carcinoma: from bioinformatics to clinical validationJuan Zhu, Yi Huang, Dan Li, et al.
International Journal of Clinical and Experimental Pathology|January 16, 2020
PARP6 acts as an oncogene and positively regulates Survivin in gastric cancerXiying Sun, Yun Zhang, Mingliang Chu, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Discover Oncology|April 24, 2026
Uterine carcinosarcoma with concurrent right nephrolithiasis case reportHede Shen, Li He, Xia Ye, et al.
Scientific Reports|April 27, 2026
RETN and BMP2 as potential biomarkers for prognosis and immune landscape in lung squamous cell carcinoma: from bioinformatics to clinical validationJuan Zhu, Yi Huang, Dan Li, et al.
International Journal of Clinical and Experimental Pathology|January 16, 2020
PARP6 acts as an oncogene and positively regulates Survivin in gastric cancerXiying Sun, Yun Zhang, Mingliang Chu, et al.
Pageof 1